Sanabria FS, Lara VHP

Language: Spanish
References: 22
Page: 213-217
PDF size: 416.55 Kb.

ABSTRACT

Hemolytic uremic syndrome (HUS) is a disease primarily of infancy and early childhood. It is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. HUS has been recognized as the most common cause of acute renal failure in the pediatric population. Studies have revealed distinct subgroups of HUS and have identified several etiologies for the disease. The distinction is important because the clinical courses and prognoses differ for each category.

REFERENCES

1. Atkinson J, Goodship T. Complement factor H and the hemolytic uremic syndrome. JEM 2007; 204: 1245–1248

2. Berger S, Daha M. Complement in glomerular injury. Semin Immunopathology 2007; 29: 375–384

3. Beutin L et al. Evaluation of Major Types of Shiga Toxin 2e-Producing Escherichia coli Bacteria Present in Food, Pigs, and the Environment as Potential Pathogens for Humans. Applied and environmental microbiology 2008;74 (15): 4806–4816

4. Bielaszewska M et al. Shiga Toxin-Mediated Hemolytic Uremic Syndrome: Time to Change the Diagnostic Paradigm? PLoS ONE 2(10): e1024. doi:10.1371/journal.pone.0001024

5. Cicuta, M. Detección de Escherichia coli productor de toxina Shiga en reses bovinas y carne molida de Corrientes, Argentina. Rev. vet. 2006: 17: 1, 20–25

6. Davin J et al. Plasma therapy in atypical haemolytic uremic syndrome: lessons from a family with a factor H mutation. Pediatric Nephrology 2008; 23:1517–1521

7. Fàbregas A, et al. Enfermedad neumocócica invasiva y síndrome hemolítico urémico. An Pediatr (Barc). 2008;68(3):269-272

8. Kejariwal D. Cholelithiasis associated with haemolytic-uraemic syndrome. World Journal Gastroenteroly 2006; 12(14): 2291-2292

9. Leotta G et al. Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand. BMC Microbiology 2008; 8(46): 1-8

10. Medellin-Peña M, et al. Probiotics Affect Virulence-Related Gene Expression in Escherichia coli O157:H7. Applied and environmental microbiology 2007; 73 (13): 4259–4267

11. Mellmann A. Analysis of Collection of Hemolytic Uremic Syndrome–associated Enterohemorrhagic Escherichia coli. Emerging Infectious Diseases 2008; 14(8): 1287-1290

12. Pérez del Campo Y et al. Síndrome Hemolítico Urémico: aspectos epidemiolódgicos y patogénicos. Rev Cubana Pediatr 2000;72(3):203-13

13. Pistone V et al. Papel de la toxina Shiga en el Síndrome Urémico Hemolítico. MEDICINA (Buenos Aires) 2006; 66 (3): 11-15

14. Pistone V et al. Efecto cititóxico de la toxina Shiga tipo 2 y su subunidad B en células epiteliales tubulares renales humanas en cultivo. MEDICINA (Buenos Aires) 2005; 65: 147-150

15. Pradel N et al. Molecular Analysis of Shiga Toxin-Producing Escherichia coli Strains Isolated from Hemolytic-Uremic Syndrome Patients and Dairy Samples in France. APPLIED AND ENVIRONMENTAL MICROBIOLOGY 2008; 74 (7): 2118–2128

16. Rivas M, et al. Risk Factors for Sporadic Shiga Toxin–producing Escherichia coli Infections in Children, Argentina. Emerging Infectious Diseases 2008; 14(5): 763-771

17. Schimmer B et al. Outbreak of haemolytic uraemic syndrome in Norway caused by stx2-positive Escherichia coli O103:H25 traced to cured mutton sausages. BMC Infectious Diseases 2008; 8(41): 1-10

18. Sinha A, Rai R. Haemolytic Uraemic Syndrome Following Acute Pancreatitis. Journal of Pancreas 2005; 6(4):365-368.

19. Sorrell D. Hemolytic Uremic Syndrome. Oncology Nursing Forum 2008;35 (4); 593-596

20. Taylor M. Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome. Pediatric Nephrology 2008; 23:1425–1431

21. Venables J et al. Atypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement Gene. PLoS Med 2006; 3 (10): e431. DOI: 10.1371/journal. pmed.0030431

22. Zheng L, Sadler J. Pathogenesis of Thrombotic Microangiopathies. Annu Rev Pathol. 2008; 3: 249–277